HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masato Chiba Selected Research

3- ((6- (ethylsulfonyl)- 3- pyridinyl)oxy)- 5- (2- hydroxy- 1- methylethoxy)- N- (1- methyl- 1H- pyrazol- 3- yl)benzamide

12/2011Pharmacokinetic and pharmacodynamic properties of the glucokinase activator MK-0941 in rodent models of type 2 diabetes and healthy dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masato Chiba Research Topics

Disease

11Lung Neoplasms (Lung Cancer)
01/2021 - 11/2011
8Neoplasms (Cancer)
01/2021 - 08/2015
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 08/2016
2Colorectal Neoplasms (Colorectal Cancer)
09/2015 - 09/2010
2Body Weight (Weight, Body)
08/2015 - 03/2015
2Type 2 Diabetes Mellitus (MODY)
09/2014 - 12/2011
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021
1Chronic Obstructive Pulmonary Disease (COPD)
09/2021
1Disease Progression
10/2020
1Amyloidosis
06/2019
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
06/2019
1Lymphoma (Lymphomas)
06/2019
1Adenocarcinoma of Lung
01/2019
1Hyperalgesia
08/2018
1Neuralgia (Stump Neuralgia)
08/2018
1Osteoarthritis
08/2018
1Arthralgia (Joint Pain)
08/2018
1Interstitial Lung Diseases (Interstitial Lung Disease)
10/2017
1Adenocarcinoma
10/2017
1Body Weight Changes
08/2015
1Breast Neoplasms (Breast Cancer)
11/2014
1Hand-Foot Syndrome
09/2010

Drug/Important Bio-Agent (IBA)

7Tyrosine Kinase InhibitorsIBA
01/2021 - 04/2016
4ErbB Receptors (EGF Receptor)IBA
12/2018 - 04/2016
3AfatinibIBA
12/2021 - 03/2015
2Pharmaceutical PreparationsIBA
01/2021 - 09/2010
2osimertinibIBA
01/2021 - 04/2016
2Proteins (Proteins, Gene)FDA Link
01/2019 - 11/2014
2trifluridine tipiracil drug combinationIBA
09/2015 - 08/2015
2Trifluridine (Viroptic)FDA LinkGeneric
09/2015 - 08/2015
2GlucokinaseIBA
09/2014 - 12/2011
1tepotinibIBA
11/2022
1capmatinibIBA
11/2022
1Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2021
1Hemoglobins (Hemoglobin)IBA
09/2021
1adagrasibIBA
01/2021
1sotorasibIBA
01/2021
1fibrin fragment D (D-dimer)IBA
11/2020
1Fibrinogen (Factor I)FDA Link
11/2020
1Circulating Tumor DNAIBA
10/2020
1Methylnitronitrosoguanidine (MNNG)IBA
10/2019
1Amyloid (Amyloid Fibrils)IBA
06/2019
1HM781-36BIBA
12/2018
1Chondroitin Sulfates (Chondroitin Sulfate)IBA
08/2018
1p38 Mitogen-Activated Protein KinasesIBA
08/2018
1Therapeutic UsesIBA
01/2018
1dacomitinibIBA
01/2018
1Gefitinib (Iressa)FDA Link
01/2018
1Carcinoembryonic AntigenIBA
10/2017
1src-Family KinasesIBA
01/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2017
1Dasatinib (BMS 354825)FDA Link
01/2017
1Transforming Growth Factor beta (TGF-beta)IBA
01/2017
1Phosphotransferases (Kinase)IBA
12/2016
1tyrosine receptor (receptor, tyrosine)IBA
12/2016
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2016
1rociletinibIBA
04/2016
1Drug CombinationsIBA
09/2015
1NucleosidesIBA
09/2015
1pyrimidineIBA
09/2015
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
09/2015
1tipiracilIBA
09/2015
1DNA (Deoxyribonucleic Acid)IBA
08/2015
1neratinibIBA
03/2015
1ibrutinibIBA
03/2015
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2014
1pyridineIBA
09/2014
1ThiazolesIBA
09/2014
1TriazolesIBA
09/2014
13- ((6- (ethylsulfonyl)- 3- pyridinyl)oxy)- 5- (2- hydroxy- 1- methylethoxy)- N- (1- methyl- 1H- pyrazol- 3- yl)benzamideIBA
12/2011
1Biomarkers (Surrogate Marker)IBA
11/2011
1Vitamin B 6IBA
09/2010
1Hygroscopic AgentsIBA
09/2010
1Capecitabine (Xeloda)FDA Link
09/2010

Therapy/Procedure

4Therapeutics
01/2021 - 09/2010
2Oral Administration
08/2018 - 08/2015
1Aftercare (After-Treatment)
12/2021
1Renal Dialysis (Hemodialysis)
06/2019
1Ligation
08/2018
1Adjuvant Chemotherapy
09/2010